We are live on ! Find out more
RCMNY

Rubric Capital Management (New York) Portfolio holdings

AUM $9.44B
1-Year Est. Return 68.42%
This Fund
S&P 500
This Quarter Est. Return
+1.19%
1 Year Est. Return
+68.42%
3 Year Est. Return
+212.09%
5 Year Est. Return
+270.59%
10 Year Est. Return
–
AUM
$1.99B
AUM Growth
+$81.5M
Cap. Flow
+$144M
Cap. Flow %
7.26%
Top 10 Hldgs %
40.54%
Holding
101
New
13
Increased
27
Reduced
12
Closed
14

Top Buys

Rank Stock Value
1
MATV icon
Mativ Holdings
MATV
+$56.2M
2
NE icon
Noble Corp
NE
+$42.9M
3
DEN
Denbury Inc.
DEN
+$42.8M
4
GPRE icon
Green Plains
GPRE
+$34.6M
5
DOLE icon
Dole
DOLE
+$28.9M

Top Sells

Rank Stock Value
1
RDUS
Radius Health, Inc.
RDUS
+$72.2M
2
GEF icon
Greif
GEF
+$37.4M
3
INSM icon
Insmed
INSM
+$25.4M
4
BRSL
Brightstar Lottery PLC
BRSL
+$23.9M
5
IEA
Infrastructure and Energy Alternatives, Inc. Common Stock
IEA
+$22.6M

Sector Composition

Rank Sector Weight
1 Healthcare 23.08%
2 Industrials 19.95%
3 Energy 18.9%
4 Financials 10.05%
5 Materials 8.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMYT
26
DELISTED
Amryt Pharma plc American Depositary Shares
AMYT
$24.9M 1.25%
3,600,000
– –
CCO icon
27
Clear Channel Outdoor Holdings
CCO
$1.23B
$23.8M 1.2%
17,391,427
– –
DOLE icon
28
Dole
DOLE
$1.23B
$23.7M 1.19%
+3,249,589
New +$28.9M
KOP icon
29
Koppers
KOP
$857M
$23.6M 1.19%
1,133,840
– –
HRT
30
DELISTED
HireRight Holdings Corporation
HRT
$23.2M 1.17%
1,523,266
– –
BHC icon
31
Bausch Health
BHC
$2.32B
$22.5M 1.13%
+3,264,471
New +$22.7M
KPTI icon
32
Karyopharm Therapeutics
KPTI
$46M
$21.8M 1.1%
266,008
-27,325
-9% -$2.04M
MX icon
33
Magnachip Semiconductor
MX
$139M
$20M 1.01%
1,950,100
– –
KDNY
34
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$18.7M 0.94%
949,166
– –
KNSA icon
35
Kiniksa Pharmaceuticals
KNSA
$6.1B
$18.6M 0.94%
1,446,107
+922,579
+176% +$10.5M
DMRC icon
36
Digimarc Corp
DMRC
$167M
$16.5M 0.83%
1,214,593
– –
QNST icon
37
QuinStreet
QNST
$1.19B
$14.3M 0.72%
1,360,683
-225,241
-14% -$2.56M
SPRY icon
38
ARS Pharmaceuticals
SPRY
$601M
$14.2M 0.72%
2,695,170
+1,708,717
+173% +$8.42M
FREE
39
DELISTED
Whole Earth Brands, Inc. Class A Common Stock
FREE
$13.8M 0.69%
3,583,363
– –
RNW icon
40
ReNew
RNW
$2.48B
$13.7M 0.69%
2,279,013
– –
AVEO
41
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$13.7M 0.69%
1,664,667
+740,782
+80% +$5.69M
CMRX
42
DELISTED
Chimerix, Inc.
CMRX
$12.8M 0.64%
6,625,000
-459,604
-6% -$1.03M
NGM
43
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$11.5M 0.58%
877,161
+79,573
+10% +$1.21M
TSAT icon
44
Telesat
TSAT
$934M
$11M 0.55%
1,410,000
– –
HRTX icon
45
Heron Therapeutics
HRTX
$64.7M
$10.6M 0.53%
+2,516,328
New +$9.85M
ANIP icon
46
ANI Pharmaceuticals
ANIP
$1.73B
$9.23M 0.46%
287,046
+204,602
+248% +$7M
ARQT icon
47
Arcutis Biotherapeutics
ARQT
$3.3B
$9.02M 0.45%
472,047
+245,701
+109% +$5.57M
MREO
48
Mereo BioPharma
MREO
$48.3M
$8.93M 0.45%
10,366,120
-6,390,000
-38% -$7.82M
TRVI icon
49
Trevi Therapeutics
TRVI
$2.53B
$8.75M 0.44%
5,684,420
+3,906,000
+220% +$12.8M
ALEC icon
50
Alector
ALEC
$240M
$8.51M 0.43%
900,000
– –
1
2
3 4 5

Similar funds

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SIM
SRS Investment Management New York $9.47B AUM 60.12% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $9.38B AUM 33.37% 1-Year Est. Return
AC
Allstate Corporation Northbrook, Illinois $9.35B AUM 16.13% 1-Year Est. Return
PVI
Partners Value Investments Hamilton, Bermuda $9.34B AUM 12.2% 1-Year Est. Return
WPL
WINDACRE PARTNERSHIP LLC Houston, Texas $9.34B AUM 17.41% 1-Year Est. Return
LAMI
Longview Asset Management (Illinois) Chicago, Illinois $9.56B AUM 25.94% 1-Year Est. Return
CCMT
CMT Capital Markets Trading Frankfurt, Germany $9.56B AUM 21.2% 1-Year Est. Return

Rubric Capital Management (New York)'s Q3 2022 Portfolio in Review

As of Q3 2022, Rubric Capital Management (New York) held 101 positions worth $1.99B, up 4.3% from $1.9B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Rubric Capital Management (New York) deployed $144M of net new capital in Q3 2022, opening 13 new positions and adding to 27 existing holdings. Its largest new stake was Mativ Holdings: 2,456,759 shares worth $54.2M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 23% a quarter earlier, followed by Industrials and Energy.

On the sell side, the largest reduction was Hertz, an estimated $13.8M trimmed.

  • Rubric Capital Management (New York)'s largest Q3 2022 buy was Mativ Holdings: 2,456,759 shares worth $54.2M.
  • Rubric Capital Management (New York) added most to Mr. Cooper in Q3 2022, an estimated $19.1M increase.
  • Rubric Capital Management (New York)'s biggest Q3 2022 reduction was Hertz, cutting an estimated $13.8M.
  • Rubric Capital Management (New York) fully exited Radius Health, Inc. in Q3 2022, selling an estimated $72.2M.
  • Rubric Capital Management (New York)'s ten largest holdings make up 41% of its $1.99B portfolio in Q3 2022.
  • Rubric Capital Management (New York) opened 13 new positions and closed 14 in Q3 2022.
  • Rubric Capital Management (New York)'s portfolio value rose 4.3% quarter-over-quarter to $1.99B.

Based on Rubric Capital Management (New York)'s 13F filing for Q3 2022, filed 14 Nov 2022.